¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"expression site"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
constitutive expression
±¸¼º¹ßÇö(ϰà÷Û¡úÞ)
expression vector
¹ßÇö (Û¡úÞ) º¤ÅÍ
gene expression
À¯ÀüÀÚ ¹ßÇö(ë¶îîíÛ¡úÞ)
genetic expression
À¯Àü ¹ßÇö(ë¶îîÛ¡úÞ)
mammalian expression vector
Æ÷À¯µ¿¹°¹ßÇö(øÔêáÔÑÚªÛ¡úÞ) º¤ÅÍ
A-site-P-site moel
AÀÚ¸® PÀÚ¸® ¸ðµ¨
acceptor site
¼ö¿ëºÎÀ§ (â¥é»Ý»êÈ)
active site
Ȱ¼º(üÀàõ)ÀÚ¸®
active site-directed irreversible inhibitor
Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
alternate-site model
±³´ëºÎÀ§(ÎßÓÛÝ»êÈ)¸ðÅÚ
amino acid attachement site
¾Æ¹Ì³ë»ê(ß«) ºÎÂø(ݾó·)ÀÚ¸®
aminoacyl site
¾Æ¹Ì³ë¾Æ½Ç ÀÚ¸®
aminoacyl-tRNA site
¾Æ¹Ì³ë¾Æ½ÇtRNA ÀÚ¸®
antibody combining site
Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
antigen binding site
Ç׿ø°áÇÕ(ù÷ê«Ì¿ùê)ÀÚ¸®
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½